Splash Clinical and C2N to improve Alzheimer’s trial recruitment process
Splash Clinical and C2N Diagnostics have collaborated to enhance the recruitment process for clinical trials of Alzheimer's disease across the…
Central Nervous System
-
-
Newronika’s DBS device gains CE Mark approval for Parkinson’s treatment
Newronika has secured CE Mark approval for its AlphaDBS device aimed at the treatment of Parkinson's disease (PD), in Europe.…
-
Sooma gains FDA approval to commence study of tDCS device
Sooma Medical has received the approval of an investigational device exemption (IDE) from the US Food and Drug Administration (FDA),…
-
UCSD begins trial with Nexalin’s Halo Clarity device for mTBI and PTSD
The University of California, San Diego (UCSD) has initiated a clinical trial to assess Nexalin Technology's Halo Clarity device for…
-
QuantalX’s brain health assessment device gains CE MDR approval
QuantalX Neuroscience has gained the European CE Medical Device Regulation (MDR) approval for the Delphi-MD, a device for assessing brain…
-
Supernus wins FDA approval for Parkinson’s pump on fourth try
Supernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of Parkinson’s disease. Supernus’…
-
FDA grants 510(k) clearance for Imperative Care’s stroke thrombectomy system
The US Food and Drug Administration (FDA) has granted 510(k) clearance for Imperative Care’s Zoom System, marking an advancement in…
-
CergenX wins FDA breakthrough designation for neonatal EEG assessment tool
The US Food and Drug Administration (FDA) has granted breakthrough device designation to CergenX’s AI-powered tool for neonatal brain scans.…
-
KU ADRC partners with BYU for Alzheimer’s blood test study
The University of Kansas Alzheimer’s Disease Research Center (KU ADRC) in the US has partnered with Brigham Young University (BYU)…
-
Nyxoah introduces neurostimulator device for sleep apnoea in England
Nyxoah has introduced its Genio neurostimulator, which is intended for obstructive sleep apnoea (OSA) treatment in England, with the first…
